市場調查報告書
商品編碼
1577196
發酵槽市場到2030年的預測:按類型、操作模式、規模、材料、微生物、滅菌方法、應用和地區的全球分析Fermenters Market Forecasts to 2030 - Global Analysis By Type, Mode of Operation, Scale, Material, Microorganisms, Sterilization Technique, Application and By Geography |
根據Stratistics MRC預測,2024年全球發酵槽市場規模將達17億美元,預計2030年將達到29億美元,預測期內年複合成長率為9.2%。
發酵槽是工業發酵過程中用於培養微生物(如酵母、細菌和真菌)以生產各種生物基產品的專用容器。這些產品包括藥品、飲料、生質燃料、酵素和其他化學品。發酵槽調節溫度、pH 值、氧氣濃度和營養供應等條件,以促進有效的微生物生長和產品形成。發酵槽有各種尺寸和配置,對於生物技術、製藥以及食品和飲料加工等領域的大規模生產非常重要。
根據美國癌症協會雜誌發表的一篇科學論文,預計2022年美國將新增190萬癌症病例,609,360人將死於癌症。
生物製藥產業需求不斷成長
對生物製藥的需求不斷成長推動發酵槽市場的顯著成長。由於老年人口的快速成長、醫療保健支出的增加以及生物技術研究的進步,生物製藥領域在全球範圍內不斷擴張,對高效發酵系統的需求不斷增加。這些系統能夠生產複雜的生技藥品,包括單株抗體、重組蛋白和其他生物製藥,推動市場成長。
初始成本高
與發酵系統相關的高初始成本是市場成長的主要限制。先進的發酵技術,特別是具有精確控制能力的自動化系統,需要大量的前期投資。這種財務障礙可能會限制採用,特別是在預算有限的小型企業和研究機構中。此外,持續的運作成本以及對專業人員操作和維護這些系統的需求可能會進一步增加總體成本並減緩市場擴張。
增加對生質燃料的投資
環境問題和減少對石化燃料依賴的需求推動生質燃料生產投資的增加,為發酵槽應用創造新的途徑。隨著世界各國政府實施促進生質燃料生產的政策,將生質能轉化為乙醇和其他生質燃料的高效發酵系統的需求將會增加,預計為市場提供巨大的成長潛力。
廢棄物和產品處理
發酵過程中的廢棄物和產品特定管理的挑戰對市場成長構成威脅。隨著發酵作業規模的增加,產生的廢棄物量也隨之增加,需要符合環境法規的有效處置方法。這些廢棄物處理不當會導致環境污染和健康危害。此外,與實施永續廢棄物管理解決方案相關的成本和複雜性可能會阻止一些潛在用戶並限制市場擴張。
COVID-19 大流行對發酵槽市場產生了各種影響。儘管最初擾亂了供應鏈和製造流程,但加速了某些行業的需求。生物製藥產業加大了對用於疫苗開發和治療性蛋白質生產的發酵技術的投資。此外,疫情凸顯了國內產能的重要性,並有可能推動各地區發酵槽市場的長期成長。
預計批量發酵槽領域在預測期內將是最大的
預計批量發酵槽領域將在預測期內佔據市場佔有率。分批發酵可以更佳控制生產過程,更容易最佳化和品質保證。此方法特別適用於需要高純度產品的行業,例如藥品和精細化學品。分批發酵槽能夠靈活地容納各種原料,並且能夠小批量生產專業批次,這使其不僅適合研究和開發,而且也適合商業生產,支持其在多個行業的廣泛採用。
預計製藥和生物技術產業在預測期內年複合成長率最高
預計製藥和生物技術產業在預測期內的年複合成長率最高。這種快速成長的背後是對生物製藥的需求增加、個人化醫療的進步以及細胞和基因治療研究的進步。發酵槽在從抗生素到重組蛋白等多種醫藥產品的生產中發揮關鍵作用。醫療保健支出的增加、全球人口老化以及新型生技藥品的持續開發進一步推動了該細分市場的擴張,使其成為發酵槽市場創新和成長的關鍵驅動力。
預計歐洲在預測期內將佔據最大的市場佔有率。該地區的優勢源於其完善的生物製藥和生物技術產業、嚴格的品質標準以及對研發的大量投資。歐洲對永續生產方法(包括生質燃料和生物基化學品)有著濃厚的興趣,這進一步推動了先進發酵技術的需求。市場領先公司的存在和生物製藥生產的支持性法規環境有助於該地區獲得巨大的市場佔有率。
預計亞太地區在預測期內的年複合成長率最高。這種快速成長的推動因素包括生物技術和醫藥研究投資的增加、生質燃料需求的增加以及發酵食品意識的增強。中國和印度等國家成為生物製藥製造的主要參與者,推動了對發酵技術的需求。此外,政府支持生物技術研究和永續能源生產的舉措預計將推動該地區的市場成長,使其成為發酵槽市場擴張的熱點。
According to Stratistics MRC, the Global Fermenters Market is accounted for $1.7 billion in 2024 and is expected to reach $2.9 billion by 2030, growing at a CAGR of 9.2% during the forecast period. Fermenters are specialized vessels used in industrial fermentation processes to grow microorganisms for the production of different bio-based products, such as yeast, bacteria, or fungi. These goods may consist of medicines, beverages, biofuels, enzymes, and other chemicals. In order to facilitate effective microbial growth and product formation, fermenters maintain regulated conditions for temperature, pH, oxygen levels, and nutrient supply. They come in a variety of sizes and configurations and are essential for large-scale production in sectors such as biotechnology, pharmaceuticals, and food and beverage processing.
According to a scientific paper published in the American Cancer Society journal, it was estimated that there would be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. in 2022.
Rising demand in the biopharmaceutical industry
The increasing demand for biopharmaceuticals is driving significant growth in the fermenters market. As the biopharmaceutical sector expands globally due to a surge in geriatric population, increased healthcare expenditure, and advancements in biotechnology research, the need for efficient fermentation systems rises. These systems enable the production of complex biologics, including monoclonal antibodies, recombinant proteins, and other biopharmaceutical products, fueling market growth.
High initial costs
The high initial costs associated with fermenter systems pose a significant restraint to market growth. Advanced fermentation technologies, especially automated systems with precise control capabilities, require substantial upfront investments. This financial barrier can limit adoption, particularly among smaller companies or research institutions with budget constraints. Additionally, ongoing operational costs and the need for specialized personnel to operate and maintain these systems further contribute to the overall expense, potentially slowing market expansion.
Rising investment in biofuels
Increasing investments in biofuel production, driven by environmental concerns and the need to reduce dependence on fossil fuels, are creating new avenues for fermenter applications. As governments worldwide implement policies to promote biofuel production, the demand for efficient fermentation systems to convert biomass into ethanol and other biofuels is expected to rise, offering substantial growth potential for the market.
Disposal of waste and by-products
The challenge of managing waste and by-products from fermentation processes poses a threat to the market's growth. As fermentation operations scale up, the volume of waste generated increases, necessitating effective disposal methods that comply with environmental regulations. Improper handling of these wastes can lead to environmental contamination and health hazards. Additionally, the cost and complexity of implementing sustainable waste management solutions may deter some potential users, potentially limiting market expansion.
The COVID-19 pandemic had a mixed impact on the fermenters market. While it initially disrupted supply chains and manufacturing processes, it also accelerated demand in certain sectors. The biopharmaceutical industry saw increased investment in fermentation technologies for vaccine development and production of therapeutic proteins. Additionally, the pandemic highlighted the importance of domestic production capabilities, potentially driving long-term growth in the fermenters market across various regions.
The batch fermenters segment is expected to be the largest during the forecast period
The batch fermenters segment is expected to dominate the market share during the forecast period. Batch fermentation offers greater control over the production process, allowing for easier optimization and quality assurance. This method is particularly favored in industries requiring high-purity products, such as pharmaceuticals and fine chemicals. The flexibility of batch fermenters in handling various feedstocks and their ability to produce smaller, specialized batches make them ideal for research and development as well as commercial production, driving their widespread adoption across multiple industries.
The pharmaceuticals and biotechnology segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals and biotechnology segment is anticipated to register the highest CAGR during the forecast period. This rapid growth is driven by increasing demand for biopharmaceuticals, advancements in personalized medicine, and ongoing research in cell and gene therapies. Fermenters play a crucial role in producing a wide range of pharmaceutical products, from antibiotics to recombinant proteins. The segment's expansion is further fueled by rising healthcare expenditure, an aging global population, and the continuous development of novel biologics, positioning it as a key driver of innovation and growth in the fermenters market.
Europe is anticipated to hold the largest market share over the forecast period. The region's dominance is attributed to its well-established biopharmaceutical and biotechnology industries, stringent quality standards, and significant investments in research and development. Europe's strong focus on sustainable production methods, including biofuels and biobased chemicals, further drives the demand for advanced fermentation technologies. The presence of leading market players and a supportive regulatory environment for biopharmaceutical production contribute to the region's significant market share.
The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period. This rapid growth is driven by increasing investments in biotechnology and pharmaceutical research, rising demand for biofuels, and growing awareness of fermented food products. Countries like China and India are emerging as key players in biopharmaceutical manufacturing, driving demand for fermentation technologies. Additionally, government initiatives supporting biotech research and sustainable energy production are expected to fuel market growth in this region, making it a hotspot for fermenter market expansion.
Key players in the market
Some of the key players in Fermenters Market include Sartorius AG, Eppendorf SE, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Bioengineering AG, Infors HT, Solaris Biotechnology Srl, Applikon Biotechnology B.V., Pierre Guerin SAS, Electrolab Biotech Ltd., Finesse Solutions Inc., Bellco Glass Inc., Cellexus International Ltd., Pall Corporation, Bbi-biotech GmbH, Solida Biotech GmbH, and New Brunswick Scientific Co., Inc.
In May 2023, Thermo Fisher announced an expansion of its single-use technology manufacturing capabilities in China to support growing demand for bioproduction, including fermenters.
In March 2023, Sartorius launched the Biostat STR Generation 3, a new single-use bioreactor for manufacturing scale. It offers improved performance and ease of use for biopharmaceutical production.
In September 2022, Eppendorf introduced the BioFlo 720 bioreactor control system for microbial fermentation and cell culture applications. It offers advanced control capabilities for bench-scale through pilot-scale bioprocessing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.